Nicolas Dupin Selected Research

Lymphogranuloma Venereum

1/2019	Bacterial sexually transmitted infections in France: recent trends and patients' characteristics in 2016.
4/2010	[Sexually transmitted infections in France in 2009].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicolas Dupin Research Topics

Disease

17	Melanoma (Melanoma, Malignant) 12/2021 - 04/2007
11	Syphilis 01/2022 - 11/2009
9	Neoplasms (Cancer) 01/2021 - 03/2005
8	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2022 - 06/2002
6	Neurosyphilis (General Paresis of the Insane) 10/2021 - 04/2010
6	Infections 01/2019 - 02/2004
5	Vasculitis (Vasculitides) 01/2022 - 08/2012
4	Inflammation (Inflammations) 05/2022 - 11/2009
4	Acne Vulgaris 05/2022 - 11/2009
4	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2019 - 01/2009
3	Necrosis 01/2021 - 07/2010
3	HIV Infections (HIV Infection) 12/2015 - 01/2009
3	Castleman Disease (Castleman's Disease) 10/2007 - 04/2002
2	Primary Effusion Lymphoma 01/2022 - 10/2007
2	Pathologic Complete Response 12/2021 - 05/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 10/2016
2	Pemphigus (Pemphigus Vulgaris) 01/2020 - 05/2017
2	Agranulocytosis (Granulocytopenia) 01/2020 - 01/2020
2	Carcinogenesis 01/2020 - 10/2011
2	Lymphogranuloma Venereum 01/2019 - 04/2010
2	Pain (Aches) 09/2017 - 05/2010
2	Sarcoidosis (Schaumann Disease) 01/2015 - 10/2014
2	Fibrosis (Cirrhosis) 10/2012 - 11/2010
2	Exanthema (Rash) 06/2012 - 02/2012
2	Skin Neoplasms (Skin Cancer) 05/2011 - 12/2009
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 05/2011 - 04/2002
2	Body Weight (Weight, Body) 01/2009 - 08/2005
2	Lipodystrophy 12/2002 - 12/2002
1	Polyarteritis Nodosa (Periarteritis Nodosa) 01/2022
1	Panuveitis 12/2021
1	Erythema Multiforme 12/2021
1	Chilblains (Chilblain) 11/2021
1	Fibrosarcoma 01/2021
1	Hairy Cell Leukemia 01/2020
1	Systemic Mastocytosis 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Leukopenia 01/2019
1	Coinfection 12/2018
1	Central Nervous System Vasculitis 12/2018
1	Tinea (Ringworm) 02/2018
1	Erythema 09/2017

Drug/Important Bio-Agent (IBA)

9	VemurafenibIBA 01/2020 - 06/2013
8	Pharmaceutical PreparationsIBA 01/2021 - 12/2002
6	Biological ProductsIBA 01/2020 - 04/2010
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 02/2012
4	Penicillin G (Benzylpenicillin)FDA LinkGeneric 10/2021 - 04/2013
3	Penicillin G Benzathine (Benzathine Benzylpenicillin)FDA Link 01/2022 - 04/2010
3	Rituximab (Mabthera)FDA Link 01/2020 - 10/2003
3	Levamisole (Decaris)FDA Link 01/2019 - 08/2012
3	pembrolizumabIBA 12/2017 - 01/2017
3	AntibodiesIBA 02/2015 - 11/2010
2	Peptides (Polypeptides)IBA 05/2022 - 01/2012
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2021 - 01/2020
2	Thalidomide (Thalomid)FDA Link 12/2021 - 10/2014
2	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 10/2021 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2021 - 06/2013
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2020 - 01/2019
2	Doxycycline (Periostat)FDA LinkGeneric 07/2020 - 01/2008
2	trametinibIBA 04/2020 - 01/2020
2	dabrafenibIBA 04/2020 - 01/2020
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2019 - 08/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2018 - 01/2009
2	NivolumabIBA 12/2017 - 01/2017
2	Cocaine (Cocaine HCl)IBA 11/2016 - 08/2012
2	Biomarkers (Surrogate Marker)IBA 11/2012 - 09/2010
2	Proteins (Proteins, Gene)FDA Link 11/2012 - 01/2012
2	RNA (Ribonucleic Acid)IBA 09/2012 - 01/2010
2	telaprevirIBA 06/2012 - 02/2012
2	CytokinesIBA 01/2012 - 03/2005
2	DNA (Deoxyribonucleic Acid)IBA 10/2007 - 02/2004
1	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2022
1	Meclizine (Meclozine)FDA LinkGeneric 04/2022
1	Primaquine FDA Link 01/2022
1	Bacterial DNAIBA 01/2022
1	Colchicine FDA LinkGeneric 01/2022
1	Retinaldehyde (Retinal)IBA 12/2021
1	Interferon Type IIBA 11/2021
1	mRNA VaccinesIBA 11/2021
1	Polysaccharides (Glycans)IBA 02/2021
1	Virulence Factors (Pathogenicity Factors)IBA 02/2021
1	FibrinIBA 01/2021
1	Therapeutic UsesIBA 10/2020
1	Cetuximab (Erbitux)FDA Link 01/2020
1	Tryptases (Tryptase)IBA 01/2020
1	ImmunosorbentsIBA 01/2020
1	Proto-Oncogene Proteins B-rafIBA 01/2020
1	EnzymesIBA 01/2020
1	DesmogleinsIBA 01/2020
1	Interleukin-1 (Interleukin 1)IBA 10/2019
1	VaccinesIBA 01/2019
1	AntigensIBA 01/2019

Therapy/Procedure

12	Therapeutics 12/2021 - 10/2003
4	Highly Active Antiretroviral Therapy (HAART) 12/2018 - 11/2009
2	Immunotherapy 01/2020 - 07/2010
2	Aftercare (After-Treatment) 01/2020 - 04/2010
2	Transplantation 02/2018 - 06/2002
2	Liver Transplantation 07/2006 - 02/2004
1	Length of Stay 10/2021
1	Immunomodulation 01/2020
1	Drug Therapy (Chemotherapy) 01/2020